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Agammaglobulinemia  is a  heterogeneous  antibody  deficiency  disease,  usually  as- 
sociated with defective B lymphocytes  (1, 2). Most patients with the common varied 
form of the  disease  have  B  lymphocytes  which  do  not  synthesize  immunoglobulin 
either  in  vivo,  or  in  vitro  after  mitogenic  stimulation  (3-6).  Additionally,  a  few 
patients  with the X-linked  form of the disease also have  B  lymphocytes,  which are 
blocked in differentiation (2, 7, 8). 
Human  immunoglobulin  production has previously been observed in somatic cell 
hybrids  between  human  lymphocytes  and  mouse  myeloma  cells  (9).  Hybrid  cell 
colonies resulted only from fusions with human B lymphocytes  (10). The three major 
classes of human immunoglobulin  (IgM, IgA, and IgG) were produced by individual 
clones of hybrid cells (11). 
In  this  study  mouse  myeloma  cells  were  fused  with  B  lymphocytes  from  three 
patients with agammaglobulinemia.  Somatic cell hybrids were isolated and analyzed 
for Ig production. 
Materials and Methods 
Peripheral  lymphocytes  were  obtained  from  three  patients  with  a  primary  diagnosis  of 
agammaglobulinemia.  One patient  (patient  4-8)  had  X-linked  agammaglobulinemia  (7,  8), 
while the other two patients  (5-6 and 4-23)  had common varied agammaglobulinemia  (3, 6). 
All three patients had normal numbers ofB lymphocytes in their peripheral blood as determined 
by EAC3 rosette formation and surface Ig (3, 7). Purified B lymphocytes (more than 90% EAC3 
rosette forming) were tested for ability to synthesize immunoglobulin in vitro. Incubation with 
the  lymphocyte mitogenic factor  (LMF) l  (from  normal  T  cells)  failed to stimulate  immuno- 
globulin  synthesis  by  B  cells  from  each  of the  patients.  T  lymphocytes  from  these  patients 
produced  LMF  when  incubated  with  tetanus  toxoid.  These  results  indicate  that,  in  these 
patients, there is a primary failure ofimmunoglobulin production intrinsic to the B lymphocytes. 
Long term B lymphoid cell lines from patients 4-8 and 4-23 did not synthesize immunoglobulin 
detectable  by  [14C]leucine  incorporation.  A  lymphoid  cell  line from  patient  5-6  synthesized 
and  secreled  immunoglobulin.  In  all  three  patients,  no evidence of increased  suppressor  cell 
activity was found.  Their B  lymphocytes failed to respond  to in vitro milogenic stimttlation. 
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Participation in this study was approved by the institutional review committee, and consent 
was obtained. 
Peripheral blood was anti-coagulated with preservative-free heparin. Mononuclear  cells were 
separated by flotation on Ficoll-metrizoate (12). Because B lymphocytes uniquely form somatic 
cell hybrid colonies with mouse myeloma cell lines (10), no further fractionation of mononuclear 
cells was undertaken. The mononuclear cell preparation will be referred to as lymphocytes. 
RPC  5.4, an IgG secreting mouse myeloma cell  line resistant to 6  thioguanine (13),  was 
obtained from the Cell Distribution Center, Salk Institute, San Diego, Calif. 
All cultures were grown in Dulbecco's modified EAgle's minimal essential medium (MEM) 
supplemented with  15% heat inactivated fetal calf serum, 2 ml per  100 ml of medium of 200 
mM  L-glutamine and 0.4  ml per  100 ml medium of penicillin-streptomycin (10,000  U  and 
10,000 #g, respectively).  HAT medium was composed of 1 ×  10  -4 M hypoxanthine, 4  ×  10  -7 
M aminopterin and 1.6 ×  10  -6 M thymidine as described by Littlefield (14). HAT was added 
as a times 100 concentrate to Dulbecco's medium as indicated. 
Sendai  virus was  grown  in embryonated chicken eggs  as  previously described  (15) and 
inactivated by exposure to ultraviolet light (16). 
RPC 5.4 mouse myeloma cells and human peripheral blood lymphocytes were  fused  with 
the aid of Sendai virus (10, 11). 5-10 million mouse myeloma cells were  fused with  10-30  × 
106 human lymphocytes by the addition of 1,000-3,000  hemagglutinating units of inactivated 
Sendal virus in medium without serum at pH 7.8-8.0.  After overnight culture in medium with 
serum,  the  culture was  centrifuged and the  cells  were resuspended in medium with  HAT. 
Selection was continued for 4 days, after which the cells were collected and cloned in medium 
without hypoxanthine, aminopterin, thymidine selective medium (HAT). Hybrid cultures were 
cloned in 96  well  microplates  (Linbro Chemical Co.,  New  Haven, Conn.) as  described by 
Margulies et al. (I 7). Experiments with RPC 5.4 mouse myeloma cells showed that after 3 days 
in HAT selective medium there were no mouse parental cells capable of forming colonies and 
after 4 days there were no mouse parental cells that excluded trypan blue dye. 
Fusion experiments were performed on at least  two different occasions  with each patient's 
lymphocytes.  Parental  myeloma cells  and  hybrid colonies were  tested  for  mycoplasma by 
growth  on agar mycoplasma plates  (Grand Island Biological  Co., Grand Island, N.  Y.)  at 
frequent intervals during these experiments and were found to be without contamination. 
The chromosome constitution of each clone was determined. Cells were incubated for 24 h 
with  4  #g/ml  of  33258  Hoechst  (American  Hoechst,  Somerville,  N.  J.)  (18). They  were 
centrifuged and resuspended in medium without the dye. Metaphase chromosome spreads were 
then prepared as previously described (11, 19, 20), including  a Giemsa banding technique (21). 
Pretreatment with 33258 Hoechst resulted in the elongation  of the mouse parental chromosomal 
centromeres except for chromosomes 1 and 7, permitting rapid discrimination of human and 
mouse chromosomes. The species identity of the human chromosomes was confirmed by the 
Giemsa banding pattern. 
Hybrid cells were examined for EAC3 rosette formation (22). Sheep erythrocytes were coated 
with IgM anti-sheep hemolysin and then reacted with the first four components of complement, 
to prepare EAC3 (EAC 1423). 0.1 ml of a cell suspension containing 1-2 ×  l0  s cells was mixed 
with 0.1 ml of EAC3 suspension, centrifuged at 150 g for 5 min, and incubated at 37°C for 1-3 
h.  Percent  EAC3  rosette  formation  was  determined  by  counting at  least  200  cells  in  a 
hemocytometer. 
Rabbit antiserum to human heavy chains and to mouse Ig were purchased from Behring 
Diagnostics, Inc., Woodbury, N.Y. They were rendered species specific by cross species absorp- 
tion with myeloma proteins coupled to Sepharose 4B (23). For fluorescent antibody procedures, 
the IgG fraction of each antiserum was isolated by column chromatography on DEAE cellulose 
(0.015 M phosphate buffer, pH 6.8). They were conjugated to fluorescein isothiocyanate (FITC) 
(BioQuest, BBL & Falcon Products, Div. of Becton, Dickinson & Co.,  Cockeysville,  Md.)  as 
previously described (24). Before use, fluorescent antisera were centrifuged at 100,000 g for 1 h 
to  remove aggregated  material  (25). For immune precipitations, monospecific antiserum to 
rabbit IgG was raised in a goat. 
Hybrid cells  (1-2  ×  l0  s per ml, >90% viable by trypan blue dye exclusion) were  washed 
three times with Earle's balanced salt solution (EBSS) with heat inactivated fetal calf serum, 
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were  incubated  for  30  min  at  4°C,  washed  three  times  with  cold  EBSS,  resuspended  in 
glycerol:EBSS at  1:1, and  placed  on  microscope slides.  Slides  were  examined  with  a  Zeiss 
fluorescence microscope with an HBO 200 W mercury lamp, a BG 12 primary filter,  and a K 
510 secondary filter (Carl Zeiss, Inc., New York). 
To examine  immunoglobulin  synthesis and  secretion, cells  were  washed  with  EBSS and 
resuspended at 4  ×  106 cells per ml in Eagle's MEM with  1/10th the normal concentration of 
leucine supplemented with 10% dialyzed fetal calf serum, 1 ml of 200 mM I.-glutamine per 100 
ml  medium, and  2 #Ci.  [14C]leucine per ml  medium  (New  England Nuclear Corp., Boston, 
Mass.).  The cells were incubated for 12-16 hours, after which the medium was collected, the 
cells were washed with EBSS, resuspended in isotonic buffer (0.01 M Tris, 0.15 M NaCI, 0.0015 
M  MgC12"6H20 and  1 N  HCI to neutral  pH),  and  lysed  by the addition  of Nonidet  P-40 
(Bethesda  Research Laboratories, Rockville, Md.)  to 0.6%. After 30 min,  the cell  lysate was 
centrifuged at 2,000 g for 20 min to remove nuclei and large cell debris. 
Samples of the cell medium and of the cell lysate were examined for Ig by the addition of 
specific  antiserum  in excess  at  4°C followed  1 h  later by the addition  of goat antiserum  to 
rabbit IgG at equivalence. The mixture was incubated at 4°C for 24-48 h, washed three times 
with cold EBSS, and resuspended in 2% sodium dodecyl sulfate (SDS), 1% 2-mercaptoethanol. 
Immune precipitates were heated to 100°C for 2 min, and electrophoresed in 7.5% acrylamide 
slab  gels  with  SDS-phosphate buffer  (26).  The slab  gels  were dried  in  a  Hoefer gel  drying 
apparatus  (Hoefer Scientific Instruments,  San Francisco, Calif.)  and autoradiographed with 
Kodak RPR 54 X-ray film (Eastman Kodak Co., Rochester, N.Y.)  to detect de novo immu- 
noglobulin synthesis and secretion. 
Results 
Sendai virus-mediated fusion of RPC 5.4 mouse myeloma cells and human periph- 
eral  blood  lymphocytes from patients  diagnosed  to  have  agammaglobulinemia  re- 
sulted in proliferating clones of hybrid cells 4-6 wk after fusion. Five clones of hybrid 
cells derived  from patient  4-8 were examined  for immunologic properties;  six clones 
of hybrid cells examined were derived from lymphocytes of patient 5-6 and of patient 
4-23. 
To establish  the hybrid nature of the clones, metaphase chromosome spreads were 
prepared.  Clones  were  pretreated  for  24  h  with  33258  Hoechst  and  chromosome 
spreads were stained for Giemsa banding. The modal numbers of total chromosomes 
and of human chromosomes were determined  for each hybrid clone (Table I). RPC 
5.4  mouse  parental  myeloma cells  had  a  modal  number of 59 chromosomes, all  of 
which were acrocentric. All but one of the hybrid clones from the three patients had 
modal numbers of chromosomes which were close to the modal number of RPC 5.4 
(58  to 68).  One clone,  5.4  5-6 4-1,  had  a  modal  number of 110 chromosomes,  not 
quite  double  the  modal  number  of the  mouse  parental  cells.  In  agreement  with 
previous studies of mouse-human hybrid cells, only a  few human chromosomes were 
retained  in the hybrid cells.  The modal numbers of human chromosomes present  in 
hybrid clones were either 2 or 3, with ranges from 0 to 5 chromosomes (Table I). 
Hybrid cells  derived  from fusion of lymphocytes from patients  4-8  and  5-6 were 
examined  for the  B-cell  characteristic  of EAC3  rosette  formation.  RPC  5.4  mouse 
parental  myeloma cells did not form EAC3 rosettes.  Lymphocytes from patients  4-8 
and 5-6 included  17 and  19% EAC3 rosette-forming B cells, respectively. None of the 
5.4 4-8 or 5.4 5-6 hybrid cell clones formed EAC3 rosettes. These results are contrasted 
with 53% rosette-forming cells from the Epstein-Barr virus transformed lymphoid cell 
line, LAZ  135, derived from the B lymphocytes of patient  5-6. 
Surface  immunoglobulin  was  examined  by immunofluorescence  with  FITC-con- JERROLD F.  SCHWABER AND FRED S.  ROSEN 
TABLE I 
Chromosome Constitution of Hybrid Clones 
Modal human  Modal chromosome number  Clone  chromosome num- 
(range)  ber (range) 
5.4 4-8 
l-I  64 (61-68)  3 (1-4) 
1-3  65 (62-66)  2 (1-3) 
2-3  65 (63-66)  2 (1-3) 
3-2  59 (57-60)  2 (1-3) 
3-3  63 (60-64)  3 (2-4) 
5.4 5-6 
1-2  65 (62-68)  2 (1-3) 
1-3  64 (62-67)  2 (1-3) 
1-4  63 (58-64)  2 (1-4) 
3-2  63 (60-64)  2 (0-5) 
3-3  64 (61-65)  2 (1-3) 
4-I  It0 (100-119)  3 (0-5) 
5.4 4-23 
1-1  58 (55-6O)  2 (O-3) 
2-2  60 (58-62)  2 (1-3) 
2-4  59 (52-60)  2 (1-2) 
3-1  58 (55-62)  2 (1-4) 
3-2  59 (59-61)  2 (0-3) 
4-2  62 (61-65)  2 (1-4) 
RPC 5.4  59 (56-62)  0 
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jugated antisera  to mouse Ig and to human y, a, or #-heavy chains. The percentage 
of cells  reactive  with  each  antiserum  was determined.  Immunoglobulin  production 
was determined  by SDS-gel electrophoresis  of [14C]leucine labeled  cytoplasmic and 
secreted  proteins isolated by indirect  immune precipitation  with antiserum  directed 
against mouse Ig or human heavy chains. The immunoglobulin bearing and procmc- 
ing properties of hybrid clones will be presented according to the patient  from whom 
the human parental  lymphocytes were obtained. 
The classes of human and mouse immunoglobulin heavy chain molecules produced 
by  the  hybrid  clones  can  be  determined  by  migration  in  SDS-acrylamide  gels.  A 
representative group of autoradiographs demonstrate the range of variation of classes 
of immunoglobulin  molecules  produced.  Some clones produced  only mouse immu- 
noglobulin (Tables II-IV); ~, and L chain molecules which comigrated with RPC 5.4 
IgG myeloma protein  (Fig.  1-RPC  5.4  and  Fig.  2-clone  5.4  5-6  3-2).  Other  clones 
synthesized  mouse and  human  Ig molecules,  but  secreted  Ig molecules  of only one 
species.  Clone 5.4 4-23 4-2 had cytoplasmic human  y, #, and  L-chain molecule and 
mouse "},- and L-chain molecules  (Fig.  3). Only the mouse ~,- and L-chain molecules 
were secreted.  Other clones synthesized and secreted both human and mouse immu- 
noglobulin molecules (Fig. 4, clone 5.4 4-8 3-2). In each of these samples, the primary 
class of mouse immunoglobulin produced was IgG, which comigrated with RPC 5.4 
myeloma protein. When human immunoglobulin was produced it included molecules 
of the ),, #, and a-heavy chain classes, as well as L-chains. 
RPC  5.4 mouse parental  myeloma cells produced mouse IgG (Fig.  I).  93-95% of 
the live cells fluoresced with antiserum  to mouse Ig. They did not have receptors for 978  INDUCTION OF  lg  IN  tIUMAN-MOUSE CELL  HYBRIDS 
Fnc;.  I.  RPC  5.4 lgG.  I0  ~ RPC  5.4 parental mouse  myeloma cells were incubated for  14 h  in 
medium with 1/10th nornml concentration of leucine supplemented with 2 p,  Ci [14C]leucine  per ml 
of medium. The supernatant (medium) fraction  was collected  after centrifuging the cells into a 
pellet and divided into two aliquots. One portion was incubated with rabbit antiserum to mouse Ig, 
the other with rabbit antiserum to human heavy chains. Goat antiserum to rabbit IgG was added 
at  equivalence to  form  a  precipitate.  The  precipitates  were  washed,  redissolved,  reduced,  and 
electrophoresed in a 7.5% SDS-acrylamide slab gel. The gel was fixed, dried, and autoradiographed. 
The autoradiograph is shown. MM, medium precipitated with antiserum to mouse Ig; Mtt, medium 
precipitated  with antiserum to human heavy chains. 
heat  aggregated  rabbit  Ig.  Cultures  incorporated  [t4C]leucine into cytopla,smic and 
secreted mouse immunoglobulin which migrated as 7- and L-chains in SDS gels, 9  of 
10 subclones secreted the myeloma protein. 
Hybrid clones derived from patient 4-8 continued to produce mouse Ig (Table II). 
Fewer  hybrid  cells  fluoresced  with  FITC-antiserum  to  mouse  Ig  than  the  parental 
myeloma  cells  (31-90%  of hybrid cells).  All  five of the  clones contained some  cells 
reactive with antiserum  to human  heavy chains, Three of these had only a  few cells 
bearing human  Ig. The two remaining clones had moderate numbers of cells bearing 
human  surface Ig. 
All five of the  hybrid clones synthesized and secreted  mouse parental  Ig.  Four of 
the five clones incorporated [t4C]leucine into cytoplasmic protein identified as human 
Ig.  Three  of these clones secreted  the  human  Ig;  one clone synthesized  but  did  not ,JERROLI)  F.  SCHWABER AND FRED S.  ROSEN  979 
Fro.  2.  Autoradiograph of SDS-acrylamide  gel electrophoresis  ol proteins from clone 5.4 5-6 3-2. 
Cells were incubated with [14C]leucine  for 12-14 h. Medium (supernatant) fraction was collected 
after centrifugation. The pelleted cells were resuspended in isotonic Tris buffer and were lysed by 
the addition of Nonidet P-40 to 0.6'7,,. Large cell debris was removed by centrifugation at 2,000  g for 
2(1 rain. Portions of the cytoplasmic (cell) fraction and the supernatant  (medium) fraction were 
immunologically precipitated with antiserum to mouse [g or to human heavy chains in excess, 
followed by goat antiserum to rabbit IgG at equivalence.  The immune precipitates were redissolved, 
reduced, and electrophoresed in 7.5% SDS-acrylamide slab gels. The gels were fixed, dried, and 
autoradiographed. CIi, cell fraction, precipitated with antiserum to human heavy chains; Mtt, 
medium fraction, precipitated with antiserum to human heavy chains; CM, cell fraction, precipi- 
tated with antiserum to mouse lg; MM, medium fraction, precipitated with antiserum to mouse Ig. 
secrete human Ig. Clone 5.4 4-8  1-1  produced mouse Ig but did not produce human 
Ig. 
Six clones derived from B lymphocytes of patient 5-6 were examined. Five of the six 
clones reacted with FITC-antiserum to mouse Ig (Table III). One clone, 5.4 5-6 3-3, 
had only a  few cells (5%)  which reacted with FITC-antiserum to mouse Ig. All six of 
the clones had more than 70% of the cells reactive with FITC-antiserum to at  least 
one class  of human Ig heavy chain.  Most  of the  clones were  reactive with  FITC- 
antiserum to more than one class of human heavy chain. More than 90% of the cells 
from 5.4 5-6 3-2 reacted with each of the FITC-antisera to mouse Ig and to the three 
classes of human Ig heavy chains. 
All six of the clones synthesized and secreted radioactively labeled mouse Ig (Table 
IV).  Five of the six clones incorporated [14C]leucine into cytoplasmic material iden- 
tified as  human Ig. Three of these clones secreted  radioactively labeled human Ig. 
Two clones synthesized human Ig which was not secreted. One clone did not synthesize 
or secrete human Ig. 
Of six clones of hybrid cells resulting from the fusion of RPC 5.4 mouse myeloma Fie.  3.  Autoradiograph of SDS-gel electrophoresis of precipitated immunoglobulins from clone 
5.4  4-23  4-2.  Conditions and  labels are as  in  legend to  Fig.  2.  CH,  cell  fraction, human  heavy 
chains; MH, medium  fraction, human heavy chains; CM, cell fraction, mouse Ig;  MM, medium 
fraction, mouse Ig 
FIG.  4.  Autoradiograph of precipitated immunoglobulins from clone 5.4 4-8 3-2 electrophoresed 
in SDS acrylamide slab gel. For details, see legend to Fig. 2. CH, cell fraction, human heavy chains; 
MH, medium fraction, human heavy chains; CM, cell fraction, mouse Ig;  MM, medium fraction, 
mouse Ig 
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TABLE  II 
Characteristics of Clones of Patient  4-8 Hybrid  Cells 
981 
Clone 
% Cells reactive with FITC-antiserum to: 
Mouse lg  Human heavy chains 
Human Ig produc- 
tion detected by 
SDS-acrylamide 
gel electrophoresis 
Cyto-  Secreted 
plasmic 
y  a  # 
RPC 5.4  93  0  0  0 
5.4 4-8 
1-1  43  6  2  8 
1-3  66  12  3  7 
2-3  60  38  3  30 
3-2  31  3  5  9 
3-3  90  41  43  65 
+  + 
+  + 
+ 
+  + 
TABLE  III 
Characteristics of Clones of Patient  5-6 Hybrid Cells 
Clone 
% Cells reactive with FITC-antiserum to: 
Human Ig produc- 
tion dejected by 
SDS-acrylamide 
gel elect rophoresis 
Mouse Ig  tluman heavy chains  Cyto-  Secreted 
plasmic 
y  a  /t 
RPC 5.4  93  0  0  0  -  - 
5.4 5-6 
1-2  l(ll  35  70  40  +  + 
I-3  95  95  10  ~  +  + 
1-4  95  83  2  5  +  -- 
3-2  90  90  90  90  -  - 
3-3  5  60  80  80  +  + 
4-1  60  35  75  15  -  - 
cells and  lymphocytes from patient  4-23, five had  more than  50% of the cells reactive 
with FITC-antiserum  to mouse Ig (Table IV). The remaining clone, 5.4 4-23 2-4 had 
only a  few cells reactive with FITC-antiserum  to mouse Ig. Only two of the six clones 
had  significant  numbers  of cells  reactive  with  FITC-antiserum  to  human  Ig  heavy 
chains.  Clone 5.4  4-23  3-2  had  63%  cells reactive with anti #-chain  serum;  clone 5.4 
4-23  4-2  had  43%  cells  reactive  with  anti-a-chain  serum.  The  other  clones  had  a 
maximum  of 32% cells reactive with any single antiserum  to human  heavy chains.  In 
contrast  to hybrids  from normal individuals  (8,  10), each clone had one predominant 
class of human  Ig heavy chain.  For example, clone 5.4 4-23 3-1 had  26% cells reactive 
with  anti-human  ,/-chain  serum,  and  no cells reactive with  anti-# or a-chain  serum. 
The six clones synthesized and secreted mouse Ig. All six of the clones incorporated 
[NCJleucine into cytoplasmic protein identified as human  Ig. Only two of these clones 982  INDUCTION  OF  Ig  IN  tIUMAN-Mf)USE  CELL  IIYBRll)S 
TABLE  IV 
Characteristics of Clones of Patient 4-23 Hybrid Cells 
Clone 
% Cells reactive with FITC-antiserum to 
! luman Ig produc- 
tion detected by 
SDS-acrylamide 
gel electrophoresis 
Cyto-  Secreted  Mouse Ig  Human heavy chains  plasmic 
y  a  # 
RPC 5.4  93  0  0  0  -  - 
5.4 4.23 
1-I  93  4  1  10  +  + 
2-2  54  t4  3  29  +  + 
2-4  7  0  32  1  +  - 
3-1  81  26  0  0  +  - 
3-2  85  4  27  63  +  - 
4-2  53  10  43  26  +  - 
Ftc.  5.  Autoradiograph of immunoglobulins precipitated from clone 5.4 4-23  1-1. and electropho- 
resed in SDS-acrylamide slab gel. Conditions were as described in legend to Fig. 2. CH, cell fraction, 
human  heavy chains; MH, medium fraction, human  heavy chains; CM, cell fraction, mouse Ig; 
MM, medium fraction, mouse Ig. 
secreted  radioactively  labeled  human  Ig.  The  other  four hybrid  clones did not secrete 
human  Ig. 
An  apparent  mouse  immunoglobulin  molecule  other  than,  or  in  addition  to  the 
RPC  5.4  parental  myeloma  protein  was  found  on  an  SDS-acrylamide  gel  autoradi- JERROLD  F. SCItWABER AND FRED S.  ROSEN  983 
ograph.  Clone 5.4 4-23  1-1  had cytoplasmic #,  ),, and  L  chains which precipitated 
with  antiserum  to human  heavy chains and  to mouse Ig  (Fig.  5).  Only it- and  L- 
chains  were secreted.  We cannot  exclude the  possibility that  the  molecules which 
precipitated with antiserum to mouse Ig might represent interspecies hybrid molecules 
composed of human #-chains combined with mouse L chains. 
Discussion 
Human peripheral blood lymphocytes from three patients with agammaglobuline- 
mia were fused with RPC 5.4 mouse myeloma cells. Chromosome analysis confirmed 
the hybrid nature of each clone, indicating that most of the mouse parental chromo- 
somes were retained by the hybrids whereas few of the human parental chromosomes 
persisted. Like their myeloma parent , no clone expressed the B-cell associated surface 
receptor for the third component of complement. Most clones from each of the three 
patients synthesized and secreted mouse Ig. In addition, some clones from each of the 
three patients synthesized and secreted human Ig. Most of the clones had mouse Ig on 
their cell surface, while clones  from only one of the  patients  (5-6)  had  significant 
numbers of cells with surface human Ig. 
Long-term B lymphoid cell lines derived from each of the three patients by in vitro 
infection with Epstein-Barr virus have been studied (6, 8). Cell lines from patients 4- 
8  (LAZ  166)  and 4-23  (LAZ  153)  were primarily surface IgD bearing with a  small 
population of surface IgM bearing cells. Neither cell line secreted immunoglobulin 
nor was synthesis of cytoplasmic immunoglobulin detectable by SDS-acrylamide gel 
electrophoresis.  The  cell  line  derived  from  patient  5-6  (LAZ  135)  had  cells  with 
surface IgG, A, M, and D and synthesized and secreted immunoglobulin. 
Some somatic cell hybrid clones from all three patients synthesized and secreted 
human  immunoglobulin. This demonstrates the presence of structural genes coding 
for immunoglobulin in the genome of each of these agammaglobulinemic individuals. 
It further demonstrates that these genes direct the synthesis of immunoglobulin only 
under the influence of the mouse parental myeloma cell genome. Examination of the 
classes of human immunoglobulin demonstrated the production of human #, y, and 
a-heavy chains by one or more clones. 
Current  evidence indicates that  IgG and  IgA producing cells develop from IgM 
bearing cells (27). B cells from all three patients do not progress beyond the stage of 
surface  IgM  and  IgD  bearing  lymphocytes. The  presence of surface  IgD  suggests 
development  of the  patients'  B  cells  beyond  the  stage  at  which  individual  cells' 
isotypes are specified (27, 28). Whether isotype specification has occurred cannot be 
determined with certainty. Fusion with mouse myetoma cells results in the production 
of the three major classes of human immunoglobulin. This suggeststhat these surface 
IgD  and  IgM  bearing  B  lymphocytes  may  differentiate  into  IgM,  IgG,  or  IgA 
producing cells. 
Most  of the  somatic  cell  hybrid  clones  produced  immunoglobulin  which  was 
immunologically identified as of mouse parental origin composed of'y- and L-chains 
that  could  be  identified  as  the  RPC  5.4  parental  myeloma  protein.  Some clones 
produced IgM which precipitated with antiserum to mouse Ig. Because this antiserum 
reacts with  light  chains,  we could not  be sure that  this IgM  was  not composed of 
human #-chains with mouse L-chains. Intra- and interspecies hybrid molecules similar 
to this have been previously reported (11, 17, 29, 32). The antiserum to human Ig was 
specific for the y, a, and #-heavy chains, which permitted positive identification of 
human #-chain production in these clones. 984  INDUCTION  OF  Ig  IN  HUMAN-MOUSE  CELL  ttYBRIDS 
The hybrid cells resulting from the fusion of mouse myeloma cells with human B 
lymphocytes morphologically resemble plasma cells. The absence of receptors for the 
third component of  complement on the clones also suggests this stage of differentiation. 
This finding is expected from the predominance of the mouse parental genome and 
from the synthesis and secretion of immunoglobulin. 
Hybrid clones derived from patient 5-6 had large numbers of cells with human and 
mouse surface Ig.  This result  is  in  agreement with studies of such  hybrids using B 
lymphocytes from  normal  individuals  (11,  and J.  Schwaber,  unpublished  results). 
Clones  derived  from  patients  4-8  and  4-23,  however, had  fewer cells with  human 
surface Ig. This difference in the expression of surface Ig molecules is in accord with 
the behavior of lymphoid cell lines derived from these patients.  Lymphoid cell lines 
from patients 4-8 and 4-23 had restricted expression of surface Ig classes, with IgD as 
the primary surface Ig molecule, whereas the lymphoid cell line derived from patient 
5-6 expressed IgG, A,  M,  and  D  as surface molecules. These findings suggest  that 
there are different defects in differentiation of the B lymphocytes from these patients. 
The induction of a  gene product by somatic cell hybridization has been reported 
only a few times. Double fusion of rat hepatoma cells with each other and then with 
mouse fibroblasts resulted in the induction of mouse albumin production (30). Fusion 
of mouse hepatoma cells with human leukocytes resulted in the induction of human 
albumin production (31). Attempts to induce immunoglobulin production (17, 32-36) 
have failed. However, fusion of two parental cells capable of producing immunoglobu- 
lin has permitted continued immunogiobulin production (11,  17, 32, 34). 
Fusion of mouse myeloma cells with human lymphocytes resulted in the induction 
of human immunoglobulin production. A previous study has shown that these hybrid 
cells result exclusively from the fusion of human B lymphocytes (10). The B cells from 
these agammaglobulinemic patients are abnormal forms, incapable of differentiation 
to  immunoglobulin  secretion.  The  production  of human  immunoglobulin  by  the 
hybrids represents induction of a  hitherto unexpressed gene product  i.e.,  y- and  c~- 
heavy chain. The parental human B cells were incapable of producing immunogtobu- 
lin  for export before fusion, or of even expressing surface IgG or IgA.  We presume 
that  this  results  from  a  molecular  defect  which  is  complemented  by  the  mouse 
parental genome. 
Summary 
Somatic cell hybrid clones were isolated from the fusion of RPC 5.4 mouse myeloma 
cells and B lymphocytes from three patients with agammaglobulinemia. One patient 
had X-linked agammaglobulinemia; the remaining two patients had common varied 
agammaglobulinemia.  All  three  patients  had  B  lymphocytes which  fail  to  secrete 
immunoglobulin. The hybrid nature of the clones was established by examination of 
metaphase chromosome spreads. Most of the clones from all three patients expressed 
surface immunoglobulin of mouse and human parental origin. Clones from two of the 
patients  had  fewer cells with  surface  Ig  than  hybrids  from  normal  persons,  while 
clones from the third patient had large numbers of surface Ig fluorescent cells.  Most 
of the  clones' from  all  three  patients  synthesized  and  secreted  human  and  mouse 
immunoglobulin. As determined by sodium dodecyl sulfate acrylamide gel electro- 
phoresis of radioactively labeled proteins, clones from each of the patients produced 
human y, c~, and #-heavy chains. These studies demonstrate the presence of functional JERROLD  F.  SCHWABER  AND  FRED S.  ROSEN  985 
structural genes coding for human  immunoglobulin  heavy chains in B  lymphocytes 
of  patients  with  agammaglobulinemia.  Further,  they  represent  induction  in  the 
somatic cell hybrids of a  gene product not expressed in the parental B  lymphocytes. 
Recewed  for publication 3 May 1978. 
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